NonSubstantive Change Request Justification

Justification for Program Changes – 0920-1313, exp. date 03/31/2026

Date: 01/23/2024

The details of the proposed revisions to this ICR are summarized here:

• CDC is requesting a nonmaterial/non-substantive change to Distribution of Traceable Opioid Material Kits across U.S. and International Laboratories survey questions (Attachment 5a). The requested change adds 2 new TOM kit selections to question 1 and question 2 of the Domestic Survey. The new kits will be available for laboratories to order in March 2024 and this update will allow CDC to collect data regarding their usage and distribution as they do for the other TOM kits.

• This change will not impact the annual burden hours or the method of deployment for the survey.

Table 1 : Changes to the Domestic Survey (Att. 5a)

Page Number	Section	Proposed Revision
1	Testing Information Question 1	1. Which test kit(s) are you requesting? (provide quantity) Fentanyl Analog Screening (FAS) Quantity [___] FAS Version 1 Quantity [___] FAS Version 2 and 3 Quantity [___] FAS Version 4 Quantity [___] Emergent Drug Panel (EDP) Quantity [___] Emergent Drug Panel – Version 1 (EDP-V1) Quantity [___] Emergent Drug Panel – Internal Standard (EDP-IS) Quantity [___]
2	Testing Information Question 2	2. Which test kit(s) have you previously received? (provide quantity) Fentanyl Analog Screening (FAS) Quantity [___] FAS Version 1 Quantity [___] FAS Version 2 and 3 Quantity [___] FAS Version 4 Quantity [___] Emergent Drug Panel (EDP) Quantity [___] Emergent Drug Panel – Version 1 (EDP-V1) Quantity [___] Emergent Drug Panel – Internal Standard (EDP-IS) Quantity [___]